Researcher.Life Logo

International Journal of Pharmaceutics: X : Impact Factor & More

eISSN: 2590-1567
JournalOpen Access

Key Metrics

Impact Factor
< 5
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on International Journal of Pharmaceutics: X

International Journal of Pharmaceutics: X Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher Elsevier
Language English
Frequency Continuous publication
Article Processing ChargesUSD 1950
Publication Time17
Editorial Review ProcessBlind peer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year2019
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 17
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessBlind peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
License typeCC BY, CC BY-NC-ND
OA statementVisit website
View less

Planning to publish in International Journal of Pharmaceutics: X ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in International Journal of Pharmaceutics: X

Determination of the optimal resistance in RS01 for robust aerosol performance of inhaled controlled-release budesonide powder for chronic obstructive inflammatory respiratory diseases patients.
  • 1 Dec 2026
  • International journal of pharmaceutics: X
Focused ultrasound-mediated blood-brain barrier opening enhances delivery of Rg3 ginseng nanoparticles in a Parkinson's disease mouse model.
  • 1 Dec 2026
  • International journal of pharmaceutics: X
PH-responsive injectable hydrogel dressing integrating antibacteria, antioxidation, anti-inflammation, and angiogenesis for infected wound healing
  • 1 Dec 2026
  • International Journal of Pharmaceutics: X
Applicability of methylliberine as a salivary marker under postprandial conditions.
  • 1 Dec 2026
  • International journal of pharmaceutics: X
Integrating in vitro aerosol characterization and cross-species PBPK modeling to predict human lung exposure of inhaled therapeutic proteins.
  • 1 Dec 2026
  • International journal of pharmaceutics: X
PH/NIR dual-responsive implantable patch for combined photothermal and chemotherapy of tumors
  • 6 Jun 2026
  • International Journal of Pharmaceutics: X
Determination of the optimal resistance in RS01 for robust aerosol performance of inhaled controlled-release budesonide powder for chronic obstructive inflammatory respiratory diseases patients.
  • 1 Dec 2026
  • International journal of pharmaceutics: X
Focused ultrasound-mediated blood-brain barrier opening enhances delivery of Rg3 ginseng nanoparticles in a Parkinson's disease mouse model.
  • 1 Dec 2026
  • International journal of pharmaceutics: X
PH-responsive injectable hydrogel dressing integrating antibacteria, antioxidation, anti-inflammation, and angiogenesis for infected wound healing
  • 1 Dec 2026
  • International Journal of Pharmaceutics: X
Applicability of methylliberine as a salivary marker under postprandial conditions.
  • 1 Dec 2026
  • International journal of pharmaceutics: X
Integrating in vitro aerosol characterization and cross-species PBPK modeling to predict human lung exposure of inhaled therapeutic proteins.
  • 1 Dec 2026
  • International journal of pharmaceutics: X
PH/NIR dual-responsive implantable patch for combined photothermal and chemotherapy of tumors
  • 6 Jun 2026
  • International Journal of Pharmaceutics: X

FAQs on International Journal of Pharmaceutics: X